Cardiomyopathy Forum-4 指南速递
|
08:00-10:00 307 |
|---|
| 主持 Moderators | 李新立 Xinli LI, 项美香 Meixiang XIANG, 袁璟 Jing YUAN, 马为 Wei MA, 朱敏 Min ZHU | ||
|
08:00-08:20 |
《中国心肌病综合管理指南2025》——精准医学理念指导心肌病临床实践 “Chinese Guidelines for Comprehensive Management of Cardiomyopathy 2025” - Clinical Practice of Cardiomyopathy Guided by Precision Medicine Concept |
宋雷 Lei SONG | |
|
08:20-08:40 |
县域心肌病合理用药与综合管理指南 Guidelines for Rational Drug Use and Comprehensive Management of Cardiomyopathy in County-Level Hospitals |
邹玉宝 Yubao ZOU | |
|
08:40-09:00 |
从《2025 ESC心肌炎和心包炎》指南看心肌炎诊疗证据更新 Update of Myocarditis Diagnosis and Treatment Evidence from the “2025 ESC Myocarditis and Pericarditis” Guidelines |
陈瑞珍 Ruizhen CHEN | |
|
09:00-09:20 |
代谢性心肌病的诊疗原则 Diagnostic and Therapeutic Principles of Metabolic Cardiomyopathy |
金玮 Wei JIN | |
|
09:20-09:40 |
ATTR-CM的精准诊疗和多维度破局之道 Precision Diagnosis and Treatment of ATTR-CM and Multi-Dimensional Breakthrough Approaches |
罗素新 Suxin LUO | |
|
09:40-10:00 |
《心肌病心内膜心肌活检及病理检查临床应用指南》解读 Interpretation of the “Guidelines for Clinical Application of Endomyocardial Biopsy and Pathological Examination in Cardiomyopathy” |
李莉 Li LI | |
Cardiomyopathy Forum-5 临床前沿
|
10:00-12:00 307 |
|---|
| 主持 Moderators | 毛威 Wei MAO, 肖红艳 Hongyan XIAO, 郑泽琪 Zeqi ZHENG, 吕玲春 Lingchun LV | ||
|
10:00-10:20 |
国家创新1.1新药物：HRS-1893的安全性及药代动力学研究结果 National Innovative 1.1 New Drug: Safety and Pharmacokinetic Research Results of HRS-1893 |
康连鸣 Lianming KANG | |
|
10:20-10:40 |
非缺血性扩张型心肌病患者猝死风险评估新方案（Radiology） New Scheme for Sudden Cardiac Death Risk Assessment in Patients with Non-Ischemic Dilated Cardiomyopathy (Radiology) |
陆敏杰 Minjie LU | |
|
10:40-11:00 |
微创室间隔电切术（MESM）治疗梗阻性肥厚型心肌病 Minimally Invasive Ventricular Septal Electrocision (MESM) for Obstructive Hypertrophic Cardiomyopathy |
崔勇 Yong CUI | |
|
11:00-11:20 |
2024年心肌病年报与质控报告解读 Interpretation of the 2024 Cardiomyopathy Annual Report and Quality Control Report |
许连军 Lianjun XU | |
|
11:20-11:40 |
应用心肌肌球蛋白抑制剂对中国梗阻性肥厚型心肌病患者磁共振特征的影响（JACC：ASIA） （JACC：ASIA）：Effect of Myocardial Myosin Inhibitor Application on Magnetic Resonance Features in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy (JACC: ASIA) |
田庄 Zhuang TIAN | |
|
11:40-12:00 |
讨论 Discussion |
||